We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

BMO:TSXBank of Montreal Analysis

Data as of 2026-03-09 - not real-time

CA$192.74

Latest Price

5/10Risk

Risk Level: Medium

Executive Summary

Bank of Montreal is trading at $192.74, just above its 20‑day SMA of $196.32 and comfortably above the 50‑day SMA of $190.36, indicating a short‑term price anchor. The 30‑day volatility of ~26% and a decreasing volume trend suggest heightened short‑term uncertainty. Technical signals are mixed: the RSI sits at 47, near the neutral zone, while the MACD histogram is negative (‑0.91) with a bearish crossover, pointing to potential downside pressure. Nevertheless, the broader trend remains bullish, and the stock is supported at $188.59, providing a cushion above the recent low of $188.7. Recent news highlighted a record first‑quarter earnings beat and strong performance across core segments, reinforcing the bank’s earnings momentum. The dividend remains attractive at 3.46% with a payout ratio of 54%, underscoring a sustainable income stream.
Valuation metrics show the bank trading at a PE of 16.1, slightly below the industry average of 17.4, and a PB of 1.62, indicating modest discount relative to peers. The DCF model assigns a fair value of $522, translating to an upside of roughly 6.7%, which, while modest, suggests the stock is undervalued on a fundamentals basis. With a low beta of 0.64, the stock exhibits limited systematic risk, and its strong cash position relative to debt supports balance‑sheet resilience. Regulatory and geographic exposures are modest, as the bank’s operations are primarily Canadian with some U.S. presence, keeping sector and currency risks at low to medium levels. Given the blend of solid earnings, sustainable dividend, and modest valuation gap, the medium‑ to long‑term outlook is positive, favoring a buy stance. Investors should monitor the MACD and volume dynamics for short‑term entry timing while leveraging the dividend yield for income generation.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 5/10

Key Factors

  • price near support at $188.59
  • bearish MACD histogram
  • decreasing volume

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • record Q1 earnings beat
  • sustainable 3.46% dividend yield
  • undervalued relative to DCF

Long Term

> 3 years
Positive
Model confidence: 8/10

Key Factors

  • low systematic risk (beta 0.64)
  • strong cash position vs debt
  • consistent dividend policy

Key Metrics & Analysis

Financial Health

Revenue Growth10.00%
Profit Margin27.08%
P/E Ratio16.1
ROE10.47%
ROA0.62%
P/B Ratio1.6
Op. Cash FlowCA$16.9B
Industry P/E17.4

Technical Analysis

TrendBullish
RSI47.5
SupportCA$188.59
ResistanceCA$204.57
MA 20CA$196.32
MA 50CA$190.36
MA 200CA$171.58
MACDBearish
VolumeDecreasing
Fear & Greed Index75.89

Valuation

Fair ValueCA$521.99
Target PriceCA$205.73
Upside/Downside6.74%
GradeUndervalued
TypeValue
Dividend Yield3.46%

Risk Assessment

Beta0.64
Volatility25.96%
Sector RiskLow
Reg. RiskMedium
Geo RiskLow
Currency RiskMedium
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.